Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Interest & Investment Income (2019 - 2020)

Cyclerion Therapeutics (CYCN) has 2 years of Interest & Investment Income data on record, last reported at -$4000.0 in Q4 2020.

  • For Q4 2020, Interest & Investment Income fell 100.75% year-over-year to -$4000.0; the TTM value through Dec 2020 reached $588000.0, changed N/A, while the annual FY2020 figure was $588000.0, 71.02% down from the prior year.
  • Interest & Investment Income reached -$4000.0 in Q4 2020 per CYCN's latest filing, down from $93000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $800000.0 in Q2 2019 and bottomed at -$4000.0 in Q4 2020.